| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.096 | 0.001 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.37 | 0.002 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |